S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.
Reeb AN, Li W, Sewell W, Marlow LA, Tun HW, Smallridge RC, Copland JA, Spradling K, Chernock R, Lin RY.
Reeb AN, et al.
J Clin Endocrinol Metab. 2015 Feb;100(2):E232-42. doi: 10.1210/jc.2014-2988. Epub 2014 Nov 25.
J Clin Endocrinol Metab. 2015.
PMID: 25423568
Free PMC article.